Daxxify is the one sold on lasting longer. Its trials reported a median of about 24 weeks, but they compared it against a placebo only. Jeuveau is the one sold on costing less. It was tested directly against Botox in a large trial and performed comparably.
| The difference | Daxxify | Jeuveau |
|---|---|---|
| What else is in the vial | A stabilising peptide, no albumin | Human serum albumin |
| Cost | Launched at a premium | Positioned as the value option |
Side by side
Daxxify
Botulinum toxin type A
Several small shots into the frown lines between the eyebrows.
Jeuveau
Botulinum toxin type A
The same treatment, using a different brand of the same kind of molecule.
Daxxify
A stabilising peptide, no albumin
The only one of the main brands with no human blood protein in it.
Jeuveau
Human serum albumin
A common stabiliser, used in most toxin brands.
Daxxify
Placebo
The two main trials compared Daxxify against a placebo. No trial has compared it head to head with Jeuveau.
Jeuveau
Botox, head to head
A large trial compared Jeuveau directly against Botox at the standard dose.
Daxxify
About 24 weeks in its trials
Half the people treated still had none-or-mild frown lines at that point. The figure is not on the label. It comes from the maker's own pooled analysis.
Jeuveau
No duration figure published
Jeuveau's label states no duration. Its trials checked results on fixed dates, rather than following people until the effect wore off.
Daxxify
Launched at a premium
The price was cut within about a year.
Jeuveau
Positioned as the value option
It generally prices below the premium brands.
Daxxify
Peptide serums
There is no home version. "Botox in a bottle" creams sit on the surface of the skin.
Jeuveau
Peptide serums
Same answer. A cream cannot reach a muscle several millimetres down, so it cannot do what a shot does.
Daxxify
Jeuveau
Daxxify
Daxxify was tested against a placebo. That is enough to earn FDA approval, and it tells you Daxxify works. It does not tell you how Daxxify stacks up against other brands on the market.
Jeuveau
Jeuveau was tested against Botox. One group got Jeuveau, one got Botox, and one got a placebo. Both real products beat the placebo by a wide margin. Jeuveau performed comparably to Botox.
That trial was built to show Jeuveau was not worse than Botox. It was not built to show it was better. Jeuveau's number came out slightly higher. That gap is not a win, because the study was never designed to find one.
Daxxify
The figure comes from Daxxify's own trials. Half the people treated still had frown lines rated none or mild at about 24 weeks. That number is not on the label.
Common questions
Botulinum toxin can cause drooping or weakness. Seek urgent care for trouble swallowing or breathing. Discuss the specific product’s warnings with your injector.